Indications: Treats fungal nail infections.
MOA: Stunts the growth of susceptible fungi by blocking an enzyme needed in producing ergosterol.
Adverse Reactions: Topical applications may cause burning, stinging, and itchiness of the skin. Oral terbinafine may alter a patient’s sense of taste.
Drug Interactions: Alcohol.
Contraindications/Cautions: Caution in patients with hepatic disease.
Comments:
Complete the full course of therapy.
Lamisil tablets should be taken with food.
Therapeutic levels of terbinafine are reached within 3-18 weeks after initiating therapy.
Therapeutic levels are maintained 2-3 weeks after treatment has ceased.
Generic Name | Brand Name(s) | Dosage Forms | Daily Dosage |
Butenafine | Mentax | Cream | Apply 1-2 times a day for 7-14 days |
Terbinafine | Lamisil | Tablet | 250 mg PO qd × 6-12 wk |
Indications: Candida infections of the skin and mucous membranes.
MOA: Inhibits the synthesis of the fungal cell membrane by binding irreversibly to ergosterol.
Adverse Reactions: Amphotericin B may cause kidney damage and hypokalemia.
Contraindications/Cautions: Patients with renal impairment.
Comments:
Complete full course of therapy.
Generic Name | Brand Name(s) | Dosage Forms | Daily Dosage |
Amphotericin B | Amphotec | IV solution | 3-4 mg/kg/day IV |
Nystatin | - | Tablet, oral suspension, topical, vaginal cream | 500,000 units PO tid |
No longer available as a branded drug in the United States.
Indications: Candida and Aspergillus infections.
MOA: Interferes with the synthesis of fungal cell wall.
Adverse Reactions: Elevated liver enzyme levels, hypokalemia, and hypotension.
Drug Interactions: Immunosuppressants.
Contraindications/Cautions: Patients with hepatic impairment.
Comments:
Oral absorption is poor, resulting in medication being administered parenterally.
Generic Name | Brand Name(s) | Dosage Forms | Daily Dosage |
Anidulafungin | Eraxis | Powder for injection | 50 mg IV q24h |
Caspofungin | Cancidas | Powder for injection | 50 mg IV q24h |
Micafungin | Mycamine | Powder for injection | 100 mg IV qd |
Indication: Onychomycosis (fungal nail infection).
MOA: Interferes with fungal mitosis.
Adverse Reactions: Gas, heartburn, nausea, and vomiting.
Drug Interactions: Warfarin, amlodipine, and oral contraceptives.
Contraindications/Cautions: Hepatic impairment, hepatic failure, and porphyria.
Comments:
Take for full course of therapy.
Griseofulvin should be taken with a fatty meal.
Generic Name | Brand Name(s) | Dosage Forms | Daily Dosage |
Griseofulvin | Gris-PEG | Capsule, tablet, oral suspension | 500 mg PO qd × 2-4 wk |
Indications: Cytomegalovirus retinitis, genital herpes, herpes simplex, herpes simplex keratitis, herpes zoster (shingles), influenza prophylaxis, organ transplants, varicella, and chickenpox.
MOA: Inhibits penetration of the host cell.
Adverse Reactions: Headaches, nausea, vomiting, diarrhea, constipation, and renal disorders.
Drug Interactions: Antiviral drug interactions are a particular problem among immunocompromised patients, because these patients are often receiving multiple different drugs for various conditions.
Contraindications/Cautions: Renal or hepatic impairment and electrolyte impairments.
Comments:
Complete full course of therapy.
Oral products should be taken with plenty of water.
When acyclovir is reconstituted, the injection solution should be used within 12 hours.
Generic Name | Brand Name | Dosage Forms | Dosage |
Acyclovir | Zovirax | Capsule, tablet, suspension, ointment | 200-800 mg q4h 5× daily for 7-10 days |
Amantadine | - | Capsule, syrup | 200 mg PO qd |
Cidofovir* | - | Solution | 5 mg/kg IV over 1h |
Famciclovir | - | Tablet | 200-1000 mg PO qd |
Foscarnet* | Foscavir | Solution | 90 mg/kg (over 1-1.5 h) q12h |
Ganciclovir* | Cytovene | Capsule, solution | 5 mg/kg IV over 1h q12h for 14-21 days |
Oseltamivir | Tamiflu | Capsule, suspension | 75 mg bid × 5 days |
Penciclovir | Denavir | Cream | Apply q2h during waking hours × 4 days |
Rimantadine | Flumadine | Tablet | 100 mg bid × 7 days |
Ribavirin* | Copegus | Tablet | 400-700 mg bid |
Valacyclovir | Valtrex | Caplet | 1000 mg PO q12h × 7-10 days |
Valganciclovir* | Valcyte | Tablet, solution | 900 mg bid × 21 days |
Zanamivir | Relenza | Inhalant | 10 mg bid × 5 days |
Medication carries a boxed warning.
No longer available as a branded drug in the United States.
Indication: Limits the progression of the retrovirus that causes HIV, which may progress to AIDS.
MOA: Inhibits the release of neuraminidase, a viral enzyme, to prevent the spread of the virus to healthy cells.
Adverse Reactions: Nausea, vomiting, and peripheral neuropathy.
Drug Interactions: St. John’s wort and alcohol.
Contraindications/Cautions: Pancreatitis and lactic acidosis.
Comments:
Take exactly as directed; don’t skip doses.
Should not be used during lactation.
Generic Name | Brand Name | Dosage Forms | Dosage |
Abacavir (ABC) | Ziagen | Tablet, solution | 300 mg PO bid or 600 mg PO qd |
Didanosine (ddl) | Videx, Videx EC | Powder for oral solution, capsule, tablet | 200 mg PO bid |
Emtricitabine (FTC) | Emtriva | Capsule, solution | 200 mg PO qd |
Lamivudine (3TC) | Epivir | Tablet, solution | 150 mg PO qd or 300 mg PO qd |
Stavudine (d4T) | Zerit | Capsule, solution | 30-40 mg PO qd |
Tenofovir (TDF) | Viread | Tablet | 300 mg PO qd |
Zidovudine (AZT) | Retrovir | Capsule, syrup, solution | 600 mg PO qd in divided doses |
Abacavir/Lamivudine | Epzicom | Tablet | 600 mg/300 mg PO qd |
Emtricitabine/Tenofovir | Truvada | Tablet | 200 mg/300 mg PO qd |
Zidovudine/Lamivudine (CBV) | Combivir | Film-coated tablet | 150 mg/300 mg PO bid |
Efavirenz/Emtricitabine/Tenofovir | Atripla | Tablet | 600 mg/200 mg/300 mg |
Emtricitabine/Rilpivirine/Tenofovir | Complera | Tablet | 200 mg/25 mg/300 mg PO qd |
Zidovudine/Lamivudine/Abacavir (TRZ) | Trizivir | Tablet | 300 mg/150 mg/300 mg PO bid |
Indications: Aids in the treatment of HIV disease.
MOA: Inhibits the action of neuraminidase, preventing the formation of proviral DNA.
Adverse Reactions: Dizziness, headache, rashes, nightmares, hallucinations, and hepatotoxicity.
Drug Interactions: Benzodiazepines, oral contraceptives, and other HIV medications.
Contraindications/Cautions: Hepatic impairment, baseline CD4 >250 (female patients), baseline CD4 >400 (male patients), HBV or HCV co-infections.
Comments:
Take exactly as directed; don’t skip doses.
Can induce or inhibit the cytochrome P450 system.
Resistance to one NNRTI results in resistance to the others.
Generic Name | Brand Name | Dosage Forms | Dosage |
Delavirdine (DLV) | Rescriptor | Tablet | 400 mg PO tid (1-2 tablets PO tid) |
Efavirenz (EFZ) | Sustiva | Capsule, tablet | 600 mg PO qd |
Etravirine | Intelence | Tablet | 200 mg PO bid |
Nevirapine (NVP) | Viramune | Tablet, suspension | 200 mg PO qd × 14 days |
Indication: Assists in the treatment of HIV.
MOA: Prevents the cleavage of certain HIV protein precursors, which are necessary for the replication of new viruses.
Adverse Reactions: Redistribution of body fat (“protease paunch” humped back), facial atrophy, breast enlargement, hyperglycemia, and hyperlipidemia.
Drug Interactions: Antianxiety agents.
Contraindications/Cautions: History of nephrolithiasis, diabetes, and hepatic impairment.
Comments:
Take exactly as prescribed; don’t skip doses.
Many protease inhibitors should be taken with food; however, check drug literature first.
Generic Name | Brand Name | Dosage Forms | Dosage |
Atazanavir | Reyataz | Capsule | 300-400 mg PO qd |
Darunavir | Prezista | Tablet | 800 mg PO qd |
Fosamprenavir (FPV) | Lexiva | Tablet, suspension | 700-1400 mg PO qd-bid |
Indinavir (IDV) | Crixivan | Capsule | 800 mg PO q8h |
Lopinavir/Ritonavir (LPV/r) | Kaletra | Solution, capsule | 400 mg/100 mg PO bid |
Nelfinavir (NFV) | Viracept | Tablet, Powder | 750 mg PO tid or 1250 mg PO bid |
Ritonavir (RTV) | Norvir | Capsule, solution | 600 mg PO bid |
Saquinavir (SQV-SGC) | Invirase | Capsule, tablet | 1000 mg PO bid |
Tipranavir | Aptivus | Capsule, solution | 500 mg PO bid |
Note: Medication carries a boxed warning.
Indication: Aids in the treatment of HIV.
MOA: Prevents the AIDS virus from entering immune cells.
Adverse Reactions: Skin reactions, which may cause bruising, cysts, itching, bumps, pain, and redness.
Drug Interactions: Orlistat.
Contraindications/Cautions: Pulmonary disease or risk of pneumonia.
Comments:
Take exactly as directed; don’t skip doses.
Enfuvirtide is diluted with sterile water.
Solution is stable for only 24 hours if refrigerated.
Generic Name | Brand Name | Dosage Form | Dosage |
Enfuvirtide | Fuzeon | SC injection | 90 mg SC bid |
Indication: Used in combination with other antiretroviral agents to treat HIV.
MOA: Binds to double-stranded viral DNA and mediates its integration into the infected host cell’s DNA to produce a provirus.
Adverse Reactions: Headache, dizziness, diarrhea, and gastrointestinal symptoms.
Drug Interactions: Aluminum hydroxide, magnesium carbonate, and magnesium citrate.
Contraindications: Anticonvulsants, lovastatin, and sildenafil.
Comments:
Take exactly as directed; don’t skip doses.
May be taken with or without food.
Generic Name | Brand Name | Dosage Form | Dosage |
Cobicistat | Tybost | Tablet | 150 mg PO qd |
Raltegravir | Isentress | Tablet | 400 mg PO bid |
Indication: Used in the treatment of HIV.
MOA: Inhibits HIV entry into host cells.
Adverse Reactions: Colds, cough, fever, and rash.
Drug Interactions: Eliguistat, carbamazepine, and St. John’s wort.
Contraindications: Patients with risk of cardiac disease, hepatic or renal impairment, and co-infection with HBV and HCV.
Comments:
May be taken with or without food.
Swallow the pill whole; do not crush, chew, or break the tablet.
Generic Name | Brand Name | Dosage Form | Dosage |
Maraviroc | Selzentry | Tablet | 300 mg PO bid |
Generic Name | Brand Name | Dosage Form | Dosage |
Abacavir/Dolutegravir/Lamivudine | Triumeq | Tablet | 600 mg/50 mg/300 mg PO qd |
Reltegravir/Cobicistat/Emtricitabine/Tenofovir Disoproxil | Stribild | Tablet | 150 mg/150 mg/300 mg PO qd |
Note: Medication carries a boxed warning.
Adverse Reactions: Menopause symptoms, alopecia, nausea, and vomiting.
Drug Interactions: DHEA, estradiol (hormone replacement), and tamoxifen.
Contraindications/Cautions: Estrogen use, pregnancy, and postmenopausal women.
Exercise precautions for handling, preparing, and administering cytotoxic drugs.
Take at the same time each day with water.
Take with meals.
Generic Name | Brand Name | Dosage Form | Dosage |
Anastrozole | Arimidex | Tablet | 1 mg PO qd |
Exemestane | Aromasin | Tablet | 25 mg PO qd |
Letrozole | Femara | Tablet | 2.5 mg PO qd |
Note: Please note that all dosages are for adults and expressed in oral dosages unless otherwise indicated.
Indications: Prostate cancer.
MOA: Increases hormone levels and is followed by desensitization to hormone’s effect.
Adverse Reactions: Anaphylaxis, bone density loss, and diabetes mellitus.
Drug Interactions: Cisapride, dronedarone, and pimozide.
Contraindications/Cautions: Pregnancy, depression, and cardiovascular disease.
Exercise precautions for handling, preparing, and administering cytotoxic drugs.
Inject according to prescribed schedule.
Store at room temperature.
Generic Name | Brand Name | Dosage Form | Dosage |
Goserelin | Zolvadex | Implant | 3.6 mg SC q 28 days |
Note: Please note that all dosages are for adults and expressed in oral dosages unless otherwise indicated.
Indication: Breast cancer.
MOA: Suppresses the release of luteinizing hormone from the pituitary glands and increases the metabolism of estrogen.
Adverse Reactions: Hot flashes, breakthrough menstrual bleeding, and weight gain.
Drug Interactions: Dofetilide and oral hypoglycemic agents.
Contraindications/Cautions: Elderly patients, patients with diabetes mellitus, and patients with a history of thromboembolisms.
Exercise precautions for handling, preparing, and administering cytotoxic drugs.
Take medication as instructed.
BUN/Cr should be monitored in elderly patients.
Generic Name | Brand Name | Dosage Form | Dosage |
Megestrol | b | Tablet, Suspension | 400-800 mg PO qd |
Note: No longer available as a branded drug in the United States.
Indication: Hodgkin lymphoma.
MOA: Forms irreversible cross-links in DNA, resulting in cells being unable to reproduce.
Adverse Reactions: Myelosuppression, alopecia, nausea, vomiting, and weight loss.
Drug Interactions: Antigout medications and vaccines.
Contraindications/Cautions: Bone marrow depression, pregnancy during the first trimester, and breastfeeding.
Exercise precautions for handling, preparing, and administering cytotoxic drugs.
Avoid aspirin, acetaminophen, and NSAIDs.
Take on an empty stomach.
Avoid dairy products within 2-3 hours of the dose.
Generic Name | Brand Name | Dosage Form | Dosage |
Cyclophosphamide | b | Tablet, Powder for Injection | 1-5 mg/kg PO qd |
Estramustine | Emcyt | Capsule | 10-16 mg/kg/day PO divided tid-qid |
Note: No longer available as a branded drug in the United States.
Indications: Breast and ovarian cancer.
MOA: Inhibits the mitosis process.
Adverse Reactions: Diarrhea, body alopecia, and nausea.
Drug Interactions: Antigout medications and live virus vaccines.
Contraindications/Cautions: Elderly patients, patients with hepatic impairment, and patients with ANC <1000 (Kaposi sarcoma).
Docetaxel and paclitaxel
Refrigerate; don’t freeze.
Protect from light.
Do not mix in PVC bags or use PVC sets.
Reconstituted docetaxel is stable for 4 hours, whereas reconstituted paclitaxel is stable for 27 hours.
Exercise precautions for handling, preparing, and administering cytotoxic drugs.
Avoid aspirin, acetaminophen, and NSAIDs.
Avoid pregnancy.
Generic Name | Brand Name | Dosage Form | Dosage |
Docetaxel | b | Powder for Injection | 60-100 mg/m² IV on day 1 of a 21-day cycle |
Paclitaxel | b | Solution | 135 mg/m² IV x 1 on day 1 of a 21-day cycle |
Note: Medication carries a boxed warning. No longer available as a branded drug in the United States.
Indications: Lung cancer, Hodgkin lymphoma, non-Hodgkin lymphoma, and testicular cancer.
MOA: Inhibits the mitosis process.
Adverse Reactions: Alopecia, joint and muscle pain, and nausea/vomiting.
Drug Interactions: Antigout medications and live virus vaccines.
Contraindications/Cautions: Granulocytopenia, neuropathy, and pulmonary disease.
Exercise precautions for handling, preparing, and administering cytotoxic drugs.
Avoid aspirin, acetaminophen, and NSAIDs.
Avoid pregnancy.
Syringes must be labeled: "Fatal if given intrathecally. For IV use only."
Generic Name | Brand Name | Dosage Form | Dosage |
Vinblastine | b | Solution, Powder for Injection | Doses may vary |
Vincristine | b | Solution | 1.4 mg/m² IV q wk |
Vinorelbine | Navelbine | Solution | 30 mg/m² x 2 IV q wk |
Note: Medication carries a boxed warning. No longer available as a branded drug in the United States.
Indications: See anthracycline table.
MOA: Damages cellular DNA.
Adverse Reactions: Anorexia, alopecia, and hepatotoxicity.
Drug Interactions: Antigout medications and live virus vaccines.
Contraindications/Cautions: History of cardiovascular disease, hepatic impairment, and myelosuppression.
Doxorubicin
Protect from light.
May cause discoloration of urine.
Exercise precautions for handling, preparing, and administering cytotoxic drugs.
Shake well (powder for injection).
Avoid pregnancy.
Generic Name | Brand Name | Indication | Dosage Form | Dosage |
Doxorubicin | b | Breast Cancer | Solution, Powder for Injection | 60-75 mg/m² IV on day 1 of a 21-day cycle |
Doxorubicin Liposomal | Doxil | Ovarian Cancer, Kaposi Sarcoma | Liposomal Dispersion | 50 mg/m² IV on day 1 of a 21-day cycle |
Epirubicin | Ellence | Breast Cancer | Solution | 75 mg/m² IV on day 1 of a 21-day cycle |
Mitoxantrone | b | Prostate Cancer, Multiple Sclerosis | Solution | 2-14 mg/m² IV on day 1 of a 21-day cycle |
Note: Medication carries a boxed warning. No longer available as a branded drug in the United States.
Indications: See topoisomerase inhibitor table.
MOA: Prevents the enzyme topoisomerase from replicating DNA or RNA transcription.
Adverse reactions: Alopecia, drowsiness, flu-like symptoms, and skin rash.
Drug interactions: Vaccines.
Contraindications/cautions: Elderly patients, patients with renal impairment, and patients with low albumin.
Comments:
Exercise precautions for handling, preparing, and administering cytotoxic drugs.
Avoid aspirin, acetaminophen, and NSAIDs.
Reconstituted solution is stable for 24 hours.
Etoposide should be swallowed whole; should not be crushed or chewed.
Avoid pregnancy.
Generic name | Brand name | Indication | Dosage forms | Dosage |
etoposide* | Etopophos | Testicular cancer | Powder for injection | 50–100 mg/m² IV on days 1–5 of 21-day cycle |
irinotecan* | Camptosar | Colorectal cancer | Solution | 25 mg/m² IV x on days 1, 8, 15, 22 of 42-day cycle |
topotecan* | Hycamtin | Ovarian cancer | Capsule, powder for injection | 1.5 mg/m² IV on days 1–5 of 21-day cycle |
*Medication carries a boxed warning.
Indications: See platinum compound table.
MOA: Causes faulty cross-linkage and defective DNA.
Adverse reactions: Loss of appetite, loss of hair, and metallic taste.
Drug interactions: NSAIDs, loop diuretics, and alcohol.
Contraindications/cautions: Renal impairment, hepatic impairment, and myelosuppression.
Comments:
Exercise precautions for handling, preparing, and administering cytotoxic drugs.
Avoid pregnancy.
Avoid aspirin, acetaminophen, and NSAIDs.
Protect from light.
Reconstituted solution and IVs are stable for 24 hours if refrigerated.
Generic name | Brand name | Indication | Dosage forms | Dosage |
carboplatin* | — | Ovarian cancer | Solution | 360 mg/m² IV x 1 on day 1 of 28-day cycle |
cisplatin* | — | Testicular and ovarian cancer | Solution | 100 mg/m² IV x 1 on day 1 of 28-day cycle |
oxaliplatin* | Eloxatin | Colon and colorectal cancer | Solution | 85 mg/m² IV on day 1 of 14-day cycle |
*Medication carries a boxed warning.
Indications: See fluoropyrimidone table.
MOA: Inhibits the enzyme responsible for making thymidine, inhibits RNA formation, and causes mismatched DNA pairs.
Adverse reactions: Upset stomach, loss of appetite, and muscle/bone pain.
Drug interactions: Vaccines.
Contraindications/cautions: Hepatic impairment, CAD, and elderly patients.
Comments:
Exercise precautions for handling, preparing, and administering cytotoxic drugs.
Avoid pregnancy.
Generic name | Brand name | Indication | Dosage forms | Dosage |
capecitabine* | Xeloda | Stage III colon cancer, colorectal and breast cancer | Tablet | 1250 mg/m² PO bid on days 1–14 of 21-day cycle |
cytarabine* | — | Leukemia | Solution, powder for injection | 100 mg/m²/day IV x 1 on days 1–7 of each cycle |
fluorouracil (5-FU) | Efudex | Basal cell cancer | Cream, solution | Apply twice a day for 2–4 weeks |
gemcitabine* | — | Ovarian cancer | Powder for injection | 1000 mg/m² IV x 1 on days 1 and 8 of 21-day cycle |
*Medication carries a boxed warning.
Indications: See antimetabolite table.
MOA: Inhibit DNA synthesis by forming abnormal nucleic acid–base pairs, resulting in abnormal DNA.
Adverse reactions: Alopecia, photosensitivity, and loss of appetite.
Drug interactions: NSAIDs, digoxin, penicillin.
Contraindications/cautions: Active infections, hepatic or renal impairment.
Comments:
Exercise precautions for handling, preparing, and administering cytotoxic drugs.
Avoid aspirin, acetaminophen, and NSAIDs.
Avoid pregnancy.
Generic name | Brand name | Indication | Dosage forms | Dosage |
mercaptopurine* | — | Lymphocytic leukemia | Tablet | 2.5–5 mg/kg PO qd |
methotrexate* | Trexall | Lung, breast, bladder, T-cell lymphomas, non-Hodgkin lymphoma | Tablet | 3.3 mg/m² PO qd |
pemetrexed | Alimta | Mesothelioma | Powder for injection | 500 mg/m² IV x 1 on day 1 of 21-day cycle |
pentostatin* | Nipent | Leukemia | Powder for injection | 4 mg/m² IV every other week |
thioguanine | Tabloid | Lymphocytic leukemia | Tablet | 2 mg/kg PO qd |
*Medication carries a boxed warning.
No longer available as a branded drug in the United States.
Indications: See miscellaneous antineoplastic table.
Adverse reactions: Pain at the injection site, fatigue, and decreased appetite.
Drug interactions: Vaccines.
Contraindications/cautions: Herpes zoster infection, varicella infection, and in elderly patients.
Comments:
Exercise precautions for handling, preparing, and administering cytotoxic drugs.
Avoid pregnancy.
Generic name | Brand name | Indication | Dosage forms | Dosage |
bleomycin* | — | Squamous cell cancer | Powder for injection | 10–20 units/m² IV/IM/SC 1–2x/wk |
dactinomycin* | Cosmegen | Testicular cancer | Powder for injection | 1000 mcg/m² IV x on day 1 of 21-day cycle for 4 cycles |
hydroxyurea* | Droxia, Hydrea | Squamous cell head/neck cancer | Capsule | 500–1000 mg PO q 12h x 11 doses of each cycle |
mitomycin* | — | Stomach cancer | Powder for injection | 20 mg/m² IV on day 42 of 56-day cycle |
porfimer | Photofrin | Esophageal cancer | Powder for injection | 2 mg/kg IV x 1 |
*Medication carries a boxed warning.
No longer available as a branded drug in the United States.
Indication: Provide artificial immunity.
MOA: Causes the recipient’s immune system to produce antibodies for the antigen or microbe found in the vaccine.
Adverse reactions: Slight fever, soreness at the injection site, and rashes.
Drug interactions: Refer to specific vaccine for information.
Contraindications/cautions:
Patients receiving steroids, radiation therapy, or antineoplastics.
Patients who are immunosuppressed or have a current moderate or severe infection that suppresses the immune system.
Patients who have received immune serum within the past 3 months.
Comments:
Extremely important for the patient to be current with their immunizations.
Many states permit the pharmacist to administer vaccines.
Generic name | Brand name | Dosage forms |
diphtheria and tetanus toxoids (Td) | Tenivac | Suspension |
diphtheria + tetanus toxoids + pertussis vaccine + tetanus toxoid conjugate vaccine | ActHIB | Powder for injection |
diphtheria and tetanus toxoids, and pertussis (DTaP) | Infanrix, Adacel, Boostrix, Daptacel | Suspension |
diptheria toxoid + hepatitis B surface antigen + pertussis vaccine + poliovirus vaccine + tetanus toxoid | Pediarix | Suspension |
Haemophilus influenzae b (Hib) conjugate vaccine | PedvaxHIB | Vaccine suspension |
hepatitis A vaccine | Havrix, Vaqta | Suspension |
hepatitis A vaccine + hepatitis B vaccine | Twinrix | Suspension |
hepatitis B vaccine | Recombivax HB | Suspension |
herpes zoster vaccine | Zostavax | Solution |
human papillomavirus* | Gardasil | Suspension |
inactivated polio vaccine | Ipol | Inactivated suspension |
influenza vaccine (formulated for selected strains) | Afluria, Fluarix Quadrivalent, FluMist Quadrivalent, FluLaval Quadrivalent, Fluvirin | Suspension |
measles, mumps, and rubella (MMR) | MMR II | Powder for injection |
measles/mumps/rubella/varicella vaccine (live) | ProQuad | Powder for injection |
meningococcal polysaccharide conjugate vaccine with diptheria toxoid | Menactra | Solution |
meningococcal vaccine | Menomune-A/C/Y/W-135 | Powder for injection |
pneumococcal polysaccharide 23-polyvalent vaccine | Pneumovax 23 | Solution |
pneumococcal polysaccharide polyvalent vaccine | Prevnar 13 | Suspension |
rabies immune globulin | HyperRAB S/D, Imovax, RabAvert | Powder for injection, solution |
rotavirus vaccine | RotaTeq | Suspension |
tetanus toxoid polysaccharide conjugate vaccine | Hiberix | Powder for injection |
varicella vaccine (live) | Varivax | Powder for injection |